Andrea Mignatti, MD
Interventional Cardiology · Manhasset, NYNPI 1245464577
Payments from drug & device makers
Across 385 payments — averaging $292.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$90K
- Inari Medical, Inc.$5K
- Edwards Lifesciences$4K
- Abiomed$3K
- Boston Scientific$3K
- W. L. Gore & Associates, Inc.$2K
- plus $6K from 16 others
What the payments were for
- Consulting fees$1,2003%
- Travel & lodging$16,29146%
- Food & beverage$17,63750%
- Education$1931%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 105 | $90,319 |
| Inari Medical, Inc. | 48 | $4,575 |
| Edwards Lifesciences | 50 | $4,009 |
| Abiomed | 41 | $3,068 |
| Boston Scientific | 35 | $3,000 |
| W. L. Gore & Associates, Inc. | 15 | $1,913 |
| Abbott | 29 | $1,684 |
| ZOLL Circulation Inc | 3 | $1,533 |
| Stryker | 20 | $632 |
| Cardiovascular Systems Inc. | 7 | $594 |
| Shockwave Medical, Inc | 6 | $356 |
| Philips North America LLC | 3 | $330 |
| Penumbra, Inc. | 2 | $171 |
| Chiesi USA, Inc. | 8 | $158 |
| Novartis | 6 | $124 |
| Boehringer Ingelheim | 1 | $114 |
| Johnson & Johnson | 1 | $21 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $20 |
| Terumo Medical Corporation | 1 | $19 |
| Bridgebio Pharma, Inc. | 1 | $17 |
| AstraZeneca | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOWTRIEVER CATHETER, S$3,592
- CT THROMBECTOMY SYSTEM KIT$3,592
- COREVALVE EVOLUT R$2,650
- TherOx DS2 Console$1,439
- Catheter$1,439
- Downstream Cartridge$1,439
- GORE CARDIOFORM Septal Occluder$1,349
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,202
- RESOLUTE ONYX$996
- VersaCross Access Solution$811
- Impella$692
- NAVITOR$563
- Coronary Orbital Atherectomy System$483
- AVVIGO Guidance System$467
- FlowTriever$466
- PASCAL$466
- PROMUS$435
- ONYX FRONTIER$392
- Peripheral Orbital Atherectomy System$345
- ClotTriever$316
How this compares
$112,689 in reported general payments places this provider in the 80th percentile of 382 interventional cardiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $7,833 |
| Metoprolol Succinate | 37 | $497 |
| Atorvastatin Calcium | 49 | $221 |
| Losartan Potassium | 18 | $193 |
| Amlodipine Besylate | 13 | $52 |
| Hydrochlorothiazide | 17 | $42 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Manhasset
- Michael KimManhasset$1.4M
- Mitchell WeinbergManhasset$779K
- Perwaiz MerajManhasset$198K
- Martin LeonNew York$13.5M
- David CohenRoslyn$9.8M
- Susheel KodaliNew York$6M
- Mohamed Azeem LatibBronx$4.6M
- Richard ShlofmitzRoslyn$4.5M
- Deepak BhattNew York$4.1M
- Samin SharmaNew York$3.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.